Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital 2024-08-29 10:00
Necessary Care or Abuse? Unpacking the Reason Behind Overprescription 2024-08-29 08:30
Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 2024-08-29 08:00
USANA Achieves HR Asia's "Best Companies to Work For" Title for Three Consecutive Years 2024-08-29 07:37
iHerb Marks its Commitment to Global Health and Wellness with 28th Anniversary Sales Event 2024-08-29 06:57
Odie's Oil Introduces Free Handbook of Toxic Finish Coatings for Finishers & Specifiers 2024-08-29 05:07
Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization 2024-08-29 04:20
UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines 2024-08-28 23:06
Fosun Int'l: Total Revenue for 1H2024 Reaches RMB97.84 Bn, Industrial Operation Profit Amounts to RMB 3.47 Bn 2024-08-28 21:51
Bloomage Showcases Key Bioactive Substances at CPHI and HI Korea 2024-08-28 21:00
Jenscare, with innovative TTVR, releases 2024H1 interim results 2024-08-28 21:00
Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Leverage Metabolomics Data to Better Understand the Molecular Mechanisms of Rheumatoid Arthritis 2024-08-28 20:00
Sasakawa Leprosy Initiative Collaborates with Miss Supranational 2024 for Leprosy Awareness Campaign in South Sulawesi, Indonesia 2024-08-28 19:00
Innovent Announces 2024 Interim Results and Business Updates 2024-08-28 18:42
Tigermed Reports 2024 Interim Results 2024-08-28 18:26
Fosun Pharma Announces 2024 Interim Results 2024-08-28 18:10
Huawei Announces All-New HUAWEI TruSense System that Will Power Upcoming Wearables 2024-08-28 17:56
Harbour BioMed Announces 2024 Interim Results 2024-08-28 17:44
Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization 2024-08-28 17:29
"Application and Awareness of Thermal Paper in Hong Kong" - Laboratory Testing and Survey Findings 2024-08-28 17:25
1 43 44 45 46 47 1596